Rijnstate Ziekenhuis

The trials here

What the 21 trials at this site are about, from their registry records.

Conditions

• Coronary artery disease3 trials
• Lung cancer3 trials
• Colorectal cancer2 trials
• Gastric and oesophageal cancer2 trials
• Heart failure2 trials
• Obesity2 trials
• Aortic aneurysm1 trial
• Atrial fibrillation1 trial
• Bladder cancer1 trial
• Childhood cancers1 trial
• Chronic kidney disease1 trial
• Diffuse large B-cell lymphoma1 trial
• and 5 more

Phase

• Phase 38 trials
• Phase 23 trials
• Phase 41 trial

Status

• Completed6 trials
• Recruiting6 trials
• Not yet recruiting4 trials
• Active, not recruiting3 trials
• Enrolling by invitation1 trial
• Terminated1 trial

Lead sponsor

• Amgen2 trials
• Leiden University Medical Center2 trials
• NovoCure GmbH2 trials
• Radboud University Medical Center2 trials
• University Medical Center Groningen2 trials
• and 11 more

Running trials

• Not yet recruiting

  SVF-Treo Study: Influence of Cardiac and Respiratory Pulsatility Deformation

  NCT07475260· University of Twente· Source

  Contact: Michel M.P.J. Reijnen

• Recruiting

  NO Re-excision MelanomA - NORMA 2

  NCT07530887· Phase 3· Marieke Goodijk· Source

  Contact: N. (Niek) Hugen

• Recruiting

  #AWARE.HIV Europe: Supporting Healthcare Professionals to Find Undiagnosed HIV in European Hospitals: An Effectiveness-implementation Trial.

  NCT06900829· Casper Rokx· Source

  Contact: Jet Gisolf, Dr.

• Active, not recruiting

  Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  NCT07037433· Phase 3· Amgen· Source

• Recruiting

  Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  NCT07037459· Phase 3· Amgen· Source

• Recruiting

  The TASTY-steering Study

  NCT07258563· University Medical Center Groningen· Source

  Contact: M. D.J.L. van der Vorst

• Recruiting

  LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

  NCT06216301· Phase 3· NovoCure GmbH· Source

  Contact: Siyar Demir

• Recruiting

  Omentum Preservation Versus Complete Omentectomy in Gastrectomy for Gastric Cancer

  NCT05180864· Amsterdam UMC· Source

  Contact: Suzanne S. Gisbertz, MD, PhD

• Recruiting

  Multi-parametric MRI in Patients Suspected for Muscle Invasive Bladder Cancer: a New Local Staging Paradigm

  NCT05779631· Radboud University Medical Center· Source

  Contact: A. G. van der Heijden, Dr.

• Recruiting

  Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)

  NCT06095583· Phase 3· Shanghai Junshi Bioscience Co., Ltd.· Source

  Contact: Claessens Niels

• Active, not recruiting

  Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Patients

  NCT05705973· Terumo Europe N.V.· Source

• Recruiting

  Aerobic Fitness or Muscle Mass Training to Improve Colorectal Cancer Outcome

  NCT04754672· Radboud University Medical Center· Source

  Contact: R. Koornstra, MD

• Active, not recruiting

  Liposomal iRInotecan, Carboplatin or oXaliplatin for Esophagogastric Cancer

  NCT03764553· Phase 2· Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)· Source

• Enrolling by invitation

  Prospective Registry on Intravascular Lithotripsy

  NCT06577038· Leiden University Medical Center· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer2 recruiting
• Aortic aneurysm1 recruiting
• Bladder cancer1 recruiting
• Childhood cancers1 recruiting
• Colorectal cancer1 recruiting
• Coronary artery disease1 recruiting
• Diffuse large B-cell lymphoma1 recruiting
• Gastric and oesophageal cancer1 recruiting
• Heart failure1 recruiting
• HIV1 recruiting
• Melanoma1 recruiting
• Obesity1 recruiting
• Triple-negative breast cancer1 recruiting

Closed trials

• Terminated

  LUNAR-4: Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Pembrolizumab for Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC)

  NCT06558799· Phase 2· NovoCure GmbH· Source

• Completed

  Digoxin Evaluation in Chronic Heart Failure: Investigational Study In Outpatients in the Netherlands

  NCT03783429· Phase 4· University Medical Center Groningen· Source

• Completed

  A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease

  NCT03819153· Phase 3· Novo Nordisk A/S· Source

• Completed

  Safety and Efficiency of the YEARS Algorithm Versus Computed Tomography Pulmonary Angiography Alone for Suspected Pulmonary Embolism in Patients With Malignancy

  NCT04657120· Leiden University Medical Center· Source

• Completed

  Nivolumab Combined With Daratumumab With or Without Low-dose Cyclophosphamide

  NCT03184194· Phase 2· Amsterdam UMC, location VUmc· Source

• Completed

  Colchicine and Spironolactone in Patients with MI / SYNERGY Stent Registry

  NCT03048825· Phase 3· Population Health Research Institute· Source

• Completed

  Treatment Strategies in Colorectal Cancer Patients With Initially Unresectable Liver-only Metastases

  NCT02162563· Phase 3· Dutch Colorectal Cancer Group· Source